Science Daily16h
Innovative dual-target drug may lead to new investigational approach for breast cancer patients
Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...
manilatimes1d
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Healio1d
Dual inhibition with faricimab improves disease control in DME, neovascular AMD
Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...
Hosted on MSN3d
Ketamine shows promise for severe obsessive-compulsive disorder in new study
A recent study published in the Journal of Psychopharmacology has offered encouraging preliminary findings for individuals with severe obsessive-compulsive disorder who have not responded to standard ...
manilatimes5d
Boehringer's nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...
Health.com5d
Collagen vs. Whey: Which Protein Is Best for Muscles and Skin?
The main difference between collagen and whey protein is their amino acid profile and health benefits. Collagen's amino acids ...